B[ACKGROUND]{.smallcaps} {#sec1-1}
========================

Diabetes mellitus is a risk factor for sudden cardiac death. Cardiac autonomic neuropathy has been implicated in the causation of sudden cardiac death. Therefore a maneuver to prevent progression of cardiac autonomic neuropathy holds significance.

I[NTRODUCTION]{.smallcaps} {#sec1-2}
==========================

We earlier published interim analysis\[[@ref1][@ref2]\] of a randomized control trial in diabetes showing improvement in quality of life,\[[@ref1]\] post prandial plasma glucose and cardiac autonomic functions\[[@ref2]\] with practice of comprehensive yogic breathing program. Here we describe the final findings on completion of the study.

M[ATERIALS AND]{.smallcaps} M[ETHODS]{.smallcaps} {#sec1-3}
=================================================

In this randomized controlled trial,120 patients of type 2 diabetes, controlled on stable dose of medication, glycemic control, quality of life and cardiac autonomic functions were assessed. Patients were then randomized into two: (1) receiving standard therapy (2) receiving comprehensive yogic breathing program with Sudarshan Kriya yoga plus standard therapy for diabetes.

Glycemic control, quality of life and cardiac autonomic function tests (CAFT) were repeated after 6 months of intervention and compared with those before randomisation.

M[ATERIALS AND]{.smallcaps} M[ETHODS]{.smallcaps} {#sec1-4}
=================================================

Analysis by Student\'s *t*-test, Wilcoxon-Mann-Whitney test, and exact test for two-way symmetry. Stata/IC 11.1 software was employed.

R[ESULTS]{.smallcaps} {#sec1-5}
=====================

There was significant lowering of the postprandial but not the fasting plasma glucose and glycated hemoglobin in the SKY group compared to standard group \[[Table 1](#T1){ref-type="table"}\].

###### 

Change in parameters of glycemic control at 12 months as compared to at six months

![](IJEM-18-582-g001)

Psychological (domain 1), environmental (domain 4), and total quality of life (WHO BREF QOL) improved significantly in the SKY compared to standard group \[[Table 2](#T2){ref-type="table"}\].

###### 

WHO BREF QOL mean scores at baseline and 3 and 6 months post randomisation

![](IJEM-18-582-g002)

Total and parasympathetic cardiac autonomic functions did not show any significant difference in both groups.

On per protocol analysis, the sympathetic cardiac autonomic functions showed significant difference in the SKY to the standard group \[[Table 3](#T3){ref-type="table"}\].

###### 

Change in sympathetic functions in SKY Group at 6 months as compared to at randomization (per protocol analysis)

![](IJEM-18-582-g003)

This change in sympathetic CAFT is not seen in the standard group \[[Table 4](#T4){ref-type="table"}\]. Neither of the groups showed any significant change in intention to treat analysis.

###### 

Change in sympathetic functions in standard Group at 6 months as compared to at randomisation

![](IJEM-18-582-g004)

D[ISCUSSION]{.smallcaps} {#sec1-6}
========================

This study shows that practice of Comprehensive Yogic breathing program improves quality of life. In a chronic diseases like diabetes, quality of life is important as it effects the compliance.

It shows significant decrease in the post prandial plasma glucose and the decrease in progression of sympathetic CAFT in per protocol analysis. This means that if practiced regularly, comprehensive yogic positively effects CAFT.

Both derangement of post prandial plasma glucose\[[@ref3]\] and cardiac autonomic neuropathy\[[@ref4]\] have been implicated in sudden cardiac death in diabetes.

This study has follow up only for 6 months and shows significant effect on CAFT. Since the HbA~1~c did not change, this effect on CAFT is independent of the effect on glycemic control. It indicates that, if added to lifestyle, comprehensive yogic breathing program has potential of preventing sudden cardiac death.

Longer period follow up in larger number of patients is needed to assess effect on progress of CAFT and glycemic control. That such studies are feasible, has been shown earlier\[[@ref5]\] and this area of research needs to be explored.

C[ONCLUSIONS]{.smallcaps} {#sec1-7}
=========================

There is significant improvement in QOL, post prandial plasma glucose and sympathetic CAFT in patients practicing SKY.
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